Meeting
2013 Breast Cancer Symposium
Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).
Authors
Eleonora Teplinsky
New York University Cancer Institute, New York, NY
Eleonora Teplinsky , Amanda Valeta , Rezina Arju , Shah Giashuddin , Yasmeen Sarfraz , Melissa Alexander , Farbod Darvishian , Deborah Silvera , Paul H. Levine , Salman Hashmi , Ladan Paul , Heather J. Hoffman , Baljit Singh , Judith D. Goldberg , Tsivia Hochman , Silvia Formenti , Robert Schneider , Komal L. Jhaveri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Local/Regional Therapy,Risk Assessment, Prevention, Detection, and Screening
Sub Track
Biology in Local/Regional Management
Citation
J Clin Oncol 31, 2013 (suppl 26; abstr 60)
DOI
10.1200/jco.2013.31.26_suppl.60
Abstract #
60
Poster Bd #
D9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dapagliflozin associated to sacubitril/valsartan and relationship with cardioprotection in human cardiac cells exposed to doxorubicin and HER2-blocking agents through MyD88, NLRP3 mediated pathways.
First Author: Nicola Maurea
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effect of PD-1 inhibition on macrophage population in human tissue cultures.
First Author: Ngoc Hoang
Poster
2021 ASCO Annual Meeting
Effect of moderate physical exercise on the immune system modulation in patients with breast cancer during preoperative chemotherapy: The NEO-RUNNER study.
First Author: Ornella Garrone
Poster
2014 ASCO Annual Meeting
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer.
First Author: Kevin Kalinsky